Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

Apinya Jusakul, Ioana Cutcutache, Chern Han Yong, +55

Cancer Discovery

Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents

Sarinya Kongpetch, Veerapol Kukongviriyapan, Auemduan Prawan, +3

PLoS ONE

PathologyHeme Oxygenase-1Cancer BiologyRedox BiologyTumor Biology +16

Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma

Sarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, +15

JCO Global Oncology

Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells

Ploypailin Aneknan, Veerapol Kukongviriyapan, Auemduan Prawan, +3

Asian Pacific Journal of Cancer Prevention

Redox modulation and human bile duct cancer inhibition by curcumin

Bunliang Suphim, Auemduan Prawan, Upa Kukongviriyapan, +3

Food and Chemical Toxicology

OncologyChemoprevention StrategyBiliary TractMedicineBiliary Cancer +7

Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand

Sunitta Saensa‐Ard, Saman Leuangwattanawanit, Laddawan Senggunprai, +11

Tumor Biology

Liver Fluke InfectionPathologyTumor BiologyOncologyEndemic Area +14

Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway

Jaroon Wandee, Auemduan Prawan, Laddawan Senggunprai, +3

Life Sciences

Tumor BiologyOncologyCholangiocarcinoma CellsMedicineCisplatin Induced Inhibition +6

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma

Preawwalee Wintachai, Jing Quan Lim, Anchalee Techasen, +8

Diagnostics

Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches

Divya Khosla, Shagun Misra, Pek Lim Chu, +17

Cancers

Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway

Laddawan Senggunprai, Pattarapon Tuponchai, Veerapol Kukongviriyapan, +2

Journal of Cancer Research and Therapeutics